Segment Reporting (Tables)

9 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of segment financial information, consolidated revenue

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2023		2022		2023		2022
	(In thousands)
Consolidated revenue:
Rx Segment	$	13,805	$	13,862	$	50,486	$	42,388
Consumer Health Segment		8,928		10,337		26,181		26,833
Consolidated revenue	$	22,733	$	24,199	$	76,667	$	69,221
Consolidated net loss:
Rx Segment	$	(5,777)	$	(52,529)	$	(10,931)	$	(88,577)
Consumer Health Segment		(1,423)		(762)		(3,663)		(4,113)
Consolidated net loss	$	(7,200)	$	(53,291)	$	(14,594)	$	(92,690)

Schedule of segment financial information, consolidated net loss

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2023		2022		2023		2022
	(In thousands)
Consolidated revenue:
Rx Segment	$	13,805	$	13,862	$	50,486	$	42,388
Consumer Health Segment		8,928		10,337		26,181		26,833
Consolidated revenue	$	22,733	$	24,199	$	76,667	$	69,221
Consolidated net loss:
Rx Segment	$	(5,777)	$	(52,529)	$	(10,931)	$	(88,577)
Consumer Health Segment		(1,423)		(762)		(3,663)		(4,113)
Consolidated net loss	$	(7,200)	$	(53,291)	$	(14,594)	$	(92,690)

Schedule of segment financial information, total assets

	March 31,		June 30,
	2023		2022
	(In thousands)
Total assets:
Rx Segment	$	131,982	$	121,377
Consumer Health Segment		15,234		16,246
Consolidated assets	$	147,216	$	137,623